Alan Secures €480 Million Series G to Scale AI-Driven Prevention Insurance
Executive Summary
Digital health insurance and healthcare platform Alan has finalized an agreement for a €480 million ($550 million) Series G funding round, establishing a post-money valuation of €5.5 billion ($6.3 billion). Led by global technology investor Prosus, the capital injection marks one of the largest non-AI startup financing rounds in Europe in 2026. The funding will be leveraged to accelerate international footprint expansion—most notably challenging group benefits incumbents in Canada—and to scale Alan's proprietary, AI-driven "prevention insurance" model globally.
Investment Syndicate & Valuation Growth
The funding round was led by Amsterdam-listed investment giant Prosus, which committed €400 million ($460 million) through a combination of primary equity and secondary share purchases. The transaction also secured continued participation from existing institutional investors Teachers' Venture Growth (TVG)—the venture arm of the Ontario Teachers' Pension Plan—and Index Ventures, alongside new equity commitments from Dara Holdings.
Notably, this transaction reflects an exceptional valuation step-up of €500 million in less than 90 days. In March 2026, Alan raised an initial Series G tranche of €100 million at a €5.0 billion valuation. The rapid follow-on round underscores robust institutional demand for Alan's unique subscription-driven business model. The closing of this capital event remains subject to customary regulatory approvals, primarily from France's Prudential Supervision and Resolution Authority (ACPR).
Pioneering "Prevention Insurance" through AI
Founded in 2016 by CEO Jean-Charles Samuelian-Werve and Charles Gorintin, Alan has spent a decade shifting the healthcare paradigm away from reactive care toward a proactive model. The platform integrates health insurance coverage, physical and mental care delivery, and real-time medical reimbursements into a unified, digital experience.
By embedding advanced automation and partnering with French AI developer Mistral, Alan has optimized internal underwriting, claims processing, and customer support. This structural efficiency resulted in a 28% reduction in per-member administrative costs. Operationally, Alan surpassed €800 million in Annual Recurring Revenue (ARR) in the first quarter of 2026—representing a 53% year-over-year increase—and has achieved profitability in its domestic French market. Currently, the platform serves over 1.1 million members across 37,000 corporate clients.
Strategic Expansion Targets: Canada and Beyond
A primary strategic objective of the Series G capital is the disruption of highly concentrated international healthcare markets. A major portion of the capital has been earmarked for Alan's expansion in Canada. Having secured its license from the Office of the Superintendent of Financial Institutions (OSFI) in late 2024, Alan is the first new health insurance carrier licensed in Canada since 1957.
Since late 2025, Alan’s Canadian membership has more than tripled, serving over 100 employers and 4,100 members. The firm intends to double its Canadian workforce over the next 24 months, expanding its operations from Toronto into Montreal to offer a highly digital alternative to established legacy carriers.
Institutional Perspectives
"Healthcare presents one of the most significant global opportunities for AI-led transformation. Alan has built something unique: an integrated platform where insurance, prevention, and care delivery reinforce each other."
— Fahd Beg, Head of Investments at Prosus
"This round gives us the means to move faster: expand to new countries, deepen our product, and continue building the new standard of prevention insurance."
— Jean-Charles Samuelian-Werve, Co-Founder & CEO of Alan